PMV Pharmaceuticals
J.D. joined PMV Pharma as Controller in May 2020, immediately prior to the company’s IPO. He has over 25 years of management, finance, accounting, valuation, audit, and communications experience in Big 4 accounting, Fortune 100 companies, and both privately-held and private equity backed companies. J.D.’s career has spanned a diverse set of industries, including biotech (at PTC Therapeutics), transportation, consumer packaged goods, and software.
He began his career in Chicago at Deloitte & Touche LLP. Mr. Kern received a B.B.A. in Accounting and an M.P.A. from The University of Texas at Austin. He is a licensed C.P.A. in New Jersey.
This person is not in any offices
PMV Pharmaceuticals
1 followers
PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.